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Abstract

In order to safely and efficiently perform endovascular revascularization
procedures among acute ischemic stroke (AIS) patients, general anesthesia or sedation is
often required. However, anesthesia management during these procedures varies
significantly worldwide and the procedural logistics have not been established yet. At
some institutions AIS patients are intubated and paralyzed, while at other facilities, there
is no routine protocol. In 2011 the University Hospital used “action nurses” (critical care
float pool nurses) to provide pharmacological paralysis with sedation for intubated AIS
patients under direct supervision of the neurointerventionalist. However, clinical
outcomes among AIS patients undergoing endovascular procedures were poor. Exclusive
utilization of the anesthesia team services for this patient population regardless of the
anesthesia management modality chosen (sedation vs. general anesthesia) was introduced
in November 2012. Implementation of this project helped to improve functional
outcomes (as measured by a modified Rankin scale) among AIS patients undergoing
endovascular revascularization therapy by 26.5% at 30-days follow up as compared to
previous.

Keywords: acute ischemic stroke, general anesthesia, sedation, endovascular,
revascularization, intra-arterial, thrombolysis, interventional neuroradiology, mechanical
thrombectomy
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Introduction

Background Knowledge
Stroke continues to be the leading cause of death and disability in the United
States. Annually, approximately 800, 000 people experience a new or recurrent stroke
with an estimated mortality rate of 53%-92% (Arnaout et al., 2012). Until recently, the
only available treatment choice for acute ischemic stroke (AIS) has been intravenous (IV)
tissue-type plasminogen activator (tPA) administration. Lately, new endovascular
treatment options for AIS are evolving. Among them are intra-arterial (IA) thrombolysis
with tPA and endovascular mechanical thrombectomy.
Endovascular treatment options for AIS are among the least common procedures
that neurointerventionalists perform, with approximately eight procedures per year per
stroke center (Meyers et al., 2011). Intra-arterial tPA administration continues to be an
off-label procedure that must be delivered within six hours of symptoms onset. Moreover,
it is associated with serious complications, such as intracranial hemorrhage and ischemic
complications. Recently, there is an explosion of studies analyzing mechanical devices,
that can be used beyond the six hour window (≤ 8 hours for anterior circulation vs. ≤ 24
hours for posterior circulation strokes) and promise improved patient outcomes (Soize et
al., 2012).
As study of treatment options for AIS patients expands, it is important to evaluate
the management of these patients during endovascular revascularization procedures. In
order to safely perform these interventions, patients often require anesthesia or sedation;
however, anesthesia management practices during intra-arterial revascularization
procedures vary significantly. At some institutions, AIS patients are intubated and
paralyzed, while at other facilities, there is no routine protocol (Nichols et al., 2010).
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In most cases, the preference of the neurointerventionalist performing the procedure
dictates the choice and this choice is usually based on his/her experience and comfort
level (Abou-Chebl et al., 2010). There is a paucity of high-quality data in the medical and
nursing literature regarding the most optimal anesthesia clinical practices that should be
implemented during these procedures.
Local Problem
Endovascular revascularization procedures for AIS, especially off-label use of
endovascular thrombolysis with tPA, continues to be rare and controversial due to the
potential risk of intracranial hemorrhage and other procedure-related complications. At
the same time, the logistics of the procedure delivery have not yet been established
(Arnaout et al., 2012). The choice of conscious sedation versus general anesthesia (GA)
must be considered carefully based on the knowledge of the procedure, the patient history,
and limitations of each of the anesthesia techniques (Table 1). In some AIS patients,
intubation is necessary due to severe agitation or for airway protection (Avitsian & Somal,
2012). However, “the role of an anesthesiologist in acute ischemic stroke management
extends far beyond providing an immobile patient to minimize fluoroscopic artifacts”
(Avitsian & Somal, 2012, p. 524). Regardless of the choice of anesthesia technique, intraprocedural management of the patient’s hemodynamics (blood pressure, cardiac
arrhythmias), airway and procedural complications by the neuroanesthesia expert could
be vital to the AIS patient’s outcomes and survival.
At the author’s institution, if an endovascular revascularization procedure is
recommended for AIS, the patient is intubated in the Emergency Department (ED) and
transferred to the Interventional Radiology (IR) suite. Pharmacological paralysis
combined with sedation is provided by an ER or ICU float pool RN (“action nurse’) and
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supervised by the neurointerventionalist. Less frequently, general anesthesia is provided
by an anesthesiologist.
Each of the anesthesia management techniques has its advantages and limitations
Limitations specific to this facility’s protocol include using an “action nurse,” who is not
an expert in handling this level of responsibility. Frequently, an action nurse has never
participated in this type of procedure before; therefore, s/he might not be familiar with
the routine and expectations of the interventional neuroradiologist performing the
intervention. As a result, the nurse might not be comfortable with communicating
unexpected procedure-specific complications (i.e. hemodynamic changes) with the
neurointerventionalist effectively and in a timely manner. Moreover, s/he might not be
aware of the potential complications or how to manage them, especially since these
endovascular interventions are uncommon and there are no clear guidelines for
hemodynamic management of AIS patients. Last year, there were nine endovascular
revascularization procedures performed at the author’s facility. This number is close to
the national average.
Another concern is that ER/ICU float nurses are not always experts in managing
optimal blood pressure among AIS patients, and appropriate management of blood
pressure is crucial among this patient population. Blood pressure should not be higher
than 185/105 with thrombolytic therapy (Shaikh, 2010). At the same time, “the rapid
lowering of blood pressure could be detrimental” (Lee et al., 2004, p. S15). According to
Leonardi-Bee et al. (2002), “for every 10 mmHg of systolic blood pressure below 150
mmHg, the risk of early death increased by 3.6% and the risk of late death and
dependency increased by 17.9%” (Grise & Adeoye, 2012, p. 133). On the other hand,
“for every 10 mmHg increase in systolic blood pressure above 150 mmHg the risk of
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early death increased by 3.8%” (Grise & Adeoye, 2012, p. 133). The target pressure (2030% above the patient’s baseline on admission to the emergency department) should be
achieved gradually to maintain cerebral perfusion pressure (Lee et al., 2004). Therefore,
continuous monitoring of blood pressure with an arterial line is ideal. However, in cases
of sedation provided by an RN at the author’s facility, a radial arterial line is usually
absent. Instead a manual blood pressure measurement is taken every five minutes.
While the neurointerventionalist is fully focused on a time-sensitive procedure
(“time is brain”), it would be helpful and safer for the patient to have an anesthesia expert
be responsible for hemodynamic management rather than a sedation RN, who has to rely
on verbal orders provided by the neurointerventionalist and does not always have up to
date knowledge, especially when considering a paucity of data supporting blood pressure
management in the early stages of AIS (Grise & Adeoye, 2012). Although endovascular
revascularization procedures among AIS patients are still rare, there are other elective
and emergency neuroendovascular procedures, such as intracranial aneurysm and
arteriovenous malformation embolization, pre-operative embolization of vascular tumors,
angioplasty and stenting of the intracranial vessels, that neurointerventionalists perform.
All of the above neuroendovascular interventions, are always performed with the
involvement of the anesthesia team at the author’s institution. Moreover, the
anesthesiologists/nurse anesthetists at the author’s facility are responsible for managing
the patients undergoing open vascular and neurovascular surgeries. Therefore, with no
doubt the anesthesia team has a higher expertise in the anesthesia management of AIS
patient population when compared to sedation nurses.
The above issue also applies to the management of cardiovascular complication
encountered during an endovascular intervention, such as cardiac arrhythmias, cardiac
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ischemia, bradycardia and heart failure. “Myocardial injury can occur immediately
preceding AIS (eg, causing cardioembolism), concurrent with AIS (eg, myocardial
infarction), or as a result of sympathetic relative hyperactivity and catecholamine release
caused by AIS” (Coplin, 2012, p. 552).
Moreover, the AIS patient population itself is a challenge as far as hemodynamic
management is concerned. Most of these patients are elderly and have multiple medical
comorbidities, such as atrial fibrillation, hypertension, hyperlipidemia, coronary artery
disease, heart failure, diabetes mellitus and obesity (Coplin, 2012). The most frequent
etiology of cardioembolic cerebral infarction includes “atrial fibrillation, recent
myocardial infarction, mechanical prosthetic valve, dilated cardiomyopathy and mitral
rheumatic stenosis” (Arboix, A. & Alio, J., 2012, p. 54). “In adults over 55 years of age,
the lifetime risk for stroke is greater than 1 in 6” (Roger, V.L. et al., 2012, p. e101). In
addition, there is often a scarcity of knowledge of the patient’s history and fasting status,
as these procedures are typically performed on an emergent basis (Young, 2007). These
factors raise the level of risk associated with anesthesia and justify the presence of an
anesthesiologist during endovascular procedures. Due to the above cardiac risks among
AIS patients, their fluid and electrolyte balance should be closely monitored during the
procedure, especially in patients with a history of heart failure, fluid overload should be
avoided. Because of their risk factors for coronary artery disease and stroke, a large
percentage of these patients are managed at baseline with either single (aspirin) or dual
antiplatelet prophylactic therapy (aspirin and plavix). A combined antiplatelet therapy
with plavix and aspirin prior to the onset of AIS, increases significantly these patients’
risk for a symptomatic intracranial hemorrhage, especially if on the top of that they also
receive either IV and/or intra-arterial tPA therapy for AIS treatment (Tarlov et al., 2012).
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There is also evidence available that shows a correlation between hyperglycemia during
the acute phase of stroke and poor outcome with endovascular revascularization therapy
(Tarlov et al., 2012). Therefore, hyperglycemia should be avoided and blood glucose
level checked routinely during the acute phase of ischemic stroke. The above points are
additional reasons to have a member of the anesthesia or neurocritical care team to
monitor and manage these patients during the endovascular revascularization procedures.
Probably the strongest contra-argument against using sedation nurses during AIS
endovascular procedures is their ability to manage the airway in non-intubated patients.
Despite the findings of a few retrospective studies revealing possible worse outcomes
with intubation during AIS endovascular revascularization procedures, intubation is
unavoidable in specific clinical situations, particularly when the patient is agitated or
unable to protect his/her airway. Adding a prolonged supine position and unknown
fasting status of these patients increases the risk of pulmonary aspiration and hypoxia
during the procedures with conscious sedation. Sometimes, emergent intra-procedural
intubation is required due to the patient’s agitation, oversedation, or decline in the
patient’s neurological status (Froehler et al., 2012). The sedation provided by sedation
nurses and supervised by a neurointerventionalist, usually is light or moderate, and not
deep sedation; unless, the patient is intubated and pharmacologically paralyzed. Deep
sedation without intubation requires skills in advanced airway management and
intubation. Neither the sedation nurse nor neuroproceduralist, is adept at rapid intubation
as it is outside their typical practice focus. “Emergent conversion to GA during the
endovascular procedure could result in patient injury from endovascular devices, hypoxia,
or aspiration and necessitates the presence of a practitioner skilled in endotracheal
intubation” (McDonagh et al., 2010, p. 3).
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In addition, a remote location of the Interventional Radiology suite, far from the
main operating rooms, decreases the chances of a rapid response from the anesthesia
team, especially when the procedure takes place during off hours (Froehler et al., 2012).
Therefore, having the anesthesia team from the beginning of the endovascular procedure
provides the patient and neurointerventionalist with the most optimal scenario, since the
anesthesiologist can facilitate different levels of sedation and emergently intubate the
patient, if necessary, without significantly delaying the opening of the occluded vessel.
Having anesthesia experience and frequent practice in airway management clinical
scenarios translates into faster revascularization treatment.
Making a decision regarding a request for anesthesia vs. a critical care float pool
nurse takes additional time and “time is brain.” Sometimes, while waiting for an action
nurse, the patient’s condition deteriorates, and an anesthesiologist is required to provide
general anesthesia for this patient. Additional waiting lowers the patient’s chances for a
good outcome (Meyers et al., 2009).
Introduction of this protocol made a decision regarding the choice of anesthesia
management easier and eliminated additional steps in the process allowing the institution
to improve performance measures (eg. time from arrival to femoral puncture for intraarterial thrombolytic infusion and/or mechanical recanalization therapy). Currently, a
request for the anesthesia team is placed as soon as the Emergency Department knows
about potential arrival of the patient with AIS.
Intended Improvement/Purpose of Change
The proposed change was the creation of a standard anesthesia management
protocol for endovascular revascularization procedures among acute ischemic stroke
patients that would always be provided by anesthesia services, but the type of anesthesia
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would be chosen based on the clinical presentation. This required classifying a
revascularization procedure as a neurologic emergency; therefore, the anesthesia team
had to be available within 15 minutes from the time request had been made.
By December 1, 2013 the University Hospital improved functional outcomes
(as measured by a modified Rankin scale) among acute ischemic stroke patients
undergoing endovascular revascularization procedures by 26.5% at 30-days follow up as
compared to the outcomes from 2011. The chosen objective was as follows:
Creation of a standard anesthesia management protocol (monitored anesthesia
care vs. general anesthesia) for endovascular revascularization procedures among
acute ischemic stroke patients, provided exclusively by a member of the
anesthesia team. Anesthesia choice is based on a clinical presentation and
determined by collaboration between the stroke neurologist,
neurointerventionalist and anesthesiologist.
These were two available options:
Option #1
Status quo: continue current process. Unfortunately, the clinical outcomes of AIS
patients who have undergone endovascular revascularization procedures at the University
Hospital are poor, their length of stay is prolonged and the healthcare cost associated with
providing care to these patients is high.
Option #2
Implement a standard anesthesia management protocol during endovascular
revascularization procedures. This process would help to start these interventions in a
timely-manner (“time is brain”), aim to improve the functional outcomes among AIS
patients, decrease the length of hospital stay and lower the healthcare costs.
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Review of the Evidence
Findings from a few recent retrospective studies have suggested a correlation
between general anesthesia (GA) and poor clinical outcomes among AIS patients
undergoing endovascular revascularization therapy (Davis et al., 2012). This data,
however, must be analyzed carefully as patients with more severe stroke (higher National
Institutes of Health Stroke Scale [NIHSS] score) were more likely to be included in the
general anesthesia group (Nichols et al., 2010). Also, while reviewing these findings, one
can notice a chronological trend toward more detailed description of the anesthesia
management logistics. The newer studies, although still retrospective, provide a clear
definition of conscious sedation, including the type of medications used and their dosages,
as well as specify who administered conscious sedation (anesthesia team vs. nonanesthesiologist). So far, however, there is no research available analyzing the outcomes
between two groups of AIS patients; those who have been managed by the anesthesia
team vs. those who have been managed by the non-anesthesiologist (eg. sedation RN
with supervision of a neurointerventionalist).
In a restrospective study by Jumaa et al. (2010), the authors compared the
outcomes of endovascular revascularization therapy in two groups of consecutive AIS
patients. One group underwent the above procedure with conscious sedation without
intubation (non-intubated state-NIS), while the other group of patients was intubated
(intubated state-IS) with general anesthesia. The authors found that length of stay in the
intensive care unit was longer for the general anesthesia group (6.5 vs. 3.2 days,
p=0.0008). Moreover, the rate of intraprocedural complications was lower among
nonintubated patients as compared to the intubated group (6% vs. 15% respectively,
p= 0.13); however, the difference was not statistically significant. Also, there were no
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significant discrepancies found in clinical outcomes and final infarct volumes on follow
up imaging between the two anesthesia management techniques. Regardless of the
anesthesia management modality (intubated state vs. nonintubated state), all procedures
in this study were performed with the involvement of an anesthesiologist.
Another retrospective study by Davis et al. (2012) attempted to identify possible
causes of poor outcome among AIS patients who had undergone endovascular
revascularization procedure with general anesthesia vs. local anesthesia/sedation. The
authors reviewed the medical records of 129 patients, who had received treatment
between January 2003 and September 2009. The study group included 96 out of 129
patients for whom 3 months post-stroke outcome scores measured with the modified
Rankin Scale (mRS) were available. The choice of anesthesia modality was a result of
collaboration between the neurologist, radiologist and anesthesiologist. In cases of local
anesthesia, light conscious sedation with IV midazolam and fentanyl was provided by the
stroke neurologist. As soon as deep sedation was needed, the patient was intubated and
light general anesthesia was delivered by an anesthesiologist. Some of the reasons for
intubation were pre-intervention aspiration, airway obstruction, or worsening in the
patient’s level of consciousness.
In addition to anesthetic technique, Davis et al. (2012) analyzed other functional
outcome predicting variables, such as patient’s age, comorbidities, the baseline stroke
severity (NIHSS score), blood pressure, blood glucose concentration, and time interval
from stroke onset to endovascular treatment. At three months post-stroke follow up,
twenty two patients (23%) had no or minimal neurologic deficits (mRS 0-1), 37 patients
(39%) were functionally independent (mRS 0-2), and 25 patients (26%) died. Mortality
rate was higher in the general anesthesia group. After adjusting for baseline stroke
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severity, sedation and no incidence of hypotension (blood pressure ≤ 140 mmHg) were
predictors of a good functional outcome. The authors reported a good functional outcome
in fifteen percent of patients managed with general anesthesia, as opposed to sixty
percent of patients who were managed with sedation (p < 0.001).
In a prospective, small size sample (36 patients) study by Soize et al. (2012), the
investigators attempted to analyze the feasibility, safety and efficacy of endovascular
mechanical thrombectomy with a Solitaire FR device under conscious sedation among
AIS patients, who presented with NIHSS score ≥ 8. The study sample included
consecutive patients with AIS caused by occlusion of a large artery (≤ 6 hours for
anterior and ≤ 24 hours for posterior circulation). The primary outcomes measured at 3months follow up were mortality rate and functional outcome. Twenty two patients
(61.1%) presented at 3-months follow up with good functional outcomes and ten patients
(27.8%) had a poor outcome or died. Successful revascularization was accomplished in
twenty eight (77.8%) patients. The anesthesia team was used only in “severe cases,” the
definition of which was not provided; whereas conscious sedation with IV midazolam
was administered by the stroke neurologist.
McDonagh et al. (2010) studied anesthesia preference for endovascular
revascularization therapy among AIS patients by surveying members of the Society of
Vascular and Interventional Neurology (SVIN) with a 12-question review. Response
rate was high at 72% (n= 49/68). As reported by survey respondents, the most frequently
used anesthesia type was general anesthesia (GA), followed by conscious sedation (nurse
administered), then monitored anesthesia care (MAC) administered by the anesthesia
team, and finally local analgesia alone. Preference for GA was associated with a type of
endovascular procedure. Mechanical thrombectomy was most frequently associated with
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a request for GA (55% of respondents). General anesthesia was a preferred practice for
patients with a NIHSS score >15 (53% of respondents) and patients with brainstem stroke
(51% of respondents). More than half (50.3%) of respondents felt strongly than any
mechanical manipulation, such as angioplasty and/or stenting required GA. Eliminating
patient’s movement, perceived procedural safety and improved procedural efficacy were
additional reasons for choosing GA. Limitations of GA included: time delay, cerebral
ischemia as a result of hypoperfusion, and lack of adequate anesthesia workforce.
Nichols and colleagues (2010) retrospectively analyzed procedural sedation
among patients from the Interventional Management of Stroke (IMS) II trial. Patients
with moderate to severe (NIHSS >10) anterior circulation strokes, who underwent
conventional cerebral angiogram and/or intra-arterial revascularization were included in
this study. While conducting IMS pilot trials I and II, the authors noticed a high level of
variation in use of peri-procedural sedation. In addition, they observed an absence of a
standard anesthesia/sedation protocol for AIS endovascular procedures. Therefore, the
emphasis of this retrospective study was the level of sedation used during the
endovascular procedures, its association with patient outcomes and factors that
influenced the level of sedation. Out of 75 patients who met the inclusion criteria, 40
(53%) received no sedation and 17 (23%) were pharmacologically paralyzed. A higher
sedation level was used for patients with aphasia, internal carotid artery occlusion and in
patients with longer procedure times. Baseline NIHSS score varied widely between the
different levels of sedation (p= 0.03). Lower levels of sedation and male gender were
correlated with good clinical outcome. The highest level of sedation, including
pharmacological paralysis, was an independent predictor of death. Mild or no sedation,
and no internal carotid artery occlusion were predictors of successful reperfusion. The
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study found a significantly higher level of infection (pneumonia and/or sepsis) in patients
who received heavy sedation (p= 0.02). High sedation level remained a predictor of poor
clinical outcome and death even after baseline NIHSS score was accounted for in
multivariable analysis. Besides a retrospective design and small sample size, Nichols and
colleagues (2010) were not able to precisely identify the types of anesthesia medications
used, the duration of the treatment, the times of administration in relation to the
angiographic procedure, and the route of administration. The authors did not specify who
provided the anesthesia management during the procedure.
Abou-Chebl and colleagues (2010) sought to examine the relationship between
the type of anesthesia used during endovascular therapy for AIS involving anterior
circulation, and patient safety and outcomes. The authors studied retrospectively a group
of 980 patients at twelve stroke centers in the United States, who underwent endovascular
therapy for AIS between 2005-2009. A total of 428 (44%) patients were placed under GA
before the procedure started. The general anesthesia group was more likely to have distal
carotid occlusion (25% vs. 15%, p <0.01) and higher NIHSS scores on admission (17±5
vs. 16±6, p<0.01) compared to the conscious sedation group. Even after the study results
were adjusted for age, initial NIHSS score, time to femoral artery puncture, time to vessel
opening, recanalization outcome, and intracerebral bleeding complication, patients placed
under GA were at significantly higher risk of a poor outcome. This study concluded that
conscious sedation seemed to be as safe as GA with respect to the procedural
complication of intracranial hemorrhage (Abou-Chebl et al., 2010). However, not
controlling for comorbidities, patient clinical status and endovascular techniques, are
some of the limitations of the study. Furthermore, the investigators did not address the
issue of emergency intubation since they could not differentiate between the group of
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patients who were intubated before the procedure and those who were intubated
emergently during the procedure. A clear definition of conscious sedation and who
managed it was not provided in the study methodology.
In the most recent study by Li et al. (2013), the researchers were attempting to
analyze the impact of the anesthesia technique on mortality rate among AIS undergoing
endovascular revascularization therapy between December 2006 and October 2012. In
their retrospective investigation they compared two groups of patients: general anesthesia
group (N= 35) vs. conscious sedation group (N= 74). They found that general anesthesia
and post-procedural hyperglycemia (blood glucose > 200 mg/dL) were the most
important predictors of mortality (mortality rate 40% vs. 22% when comparing general
anesthesia vs. conscious sedation group, p= 0.045). The time from AIS symptoms onset
to recanalization and the length of endovascular revascularization procedure were longer
in the general anesthesia group. There were no statistically significant differences
between general anesthesia and conscious sedation groups as far as procedure-related
complications (p= 0.997) and the patients’ functional outcome at discharge (p= 0.631).
However, a 90-day clinical follow up could provide more information regarding a longterm outcomes. Although the rate of pneumonia was higher in general anesthesia group
(21% vs. 16% in conscious sedation group), it had not been associated with a higher
morbidity or mortality based on this study findings. Only patients treated with Merci
retriever and Penumbra thrombectomy devices were included in this study. The
procedures performed with the latest generation of stent-retriever technology, which are
superior in performance when compared to the old generation devices (eg. Merci
retriever), were not included in this study. Before 2011, general anesthesia was used at
this institution routinely for all patients undergoing endovascular treatment for AIS. It has
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changed after 2011as neurointerventionalists had become more familiar and comfortable
with using conscious sedation for AIS patients during endovascular therapy procedures.
The retrospective study design, lack of randomization and small sample size are the
major limitations of this study.
Conceptual/Theoretical Framework
The healthcare environment is a chaotic, complex adaptive system, made up of
multiple diverse, but interconnected elements. Therefore, a Chaos Leadership Theory was
chosen as a conceptual framework to help guide the author of this project in achieving set
goals.
The first step to success according to this theory is a leadership style that “focuses
less on prediction and control and more on fostering relationships and creating conditions
in which complex adaptive systems can evolve to produce creative outcomes” (Burns, J.,
2001, p. 474). A complexity-based leadership approach is found on the assumption that
employees of a healthcare organization have the ability to self-organize and to produce
desired outcomes despite providing an impression of chaos. The relationships among the
employees are more important than the employees themselves in order to achieve
expected results. The author of this project created a general vision of the process change
while providing reasons for it, without planning every detail of the change. According to
complexity theory, leaders who raise questions that have no obvious answers (like the
one in this project: What is better, general anesthesia vs. sedation for endovascular
revascularization procedures among AIS patients), create tension and anxiety, which may
lead to increased creativity and innovation (Burns, 2001). Publishing a manuscript by the
author on the same topic started a public discussion and motivated researchers and
healthcare organizations to study this issue even further.
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According to complexity theory, “organizations that are learning should start
small, experiment to find the small things that work, and then link the successful pieces
together into more complex systems” (Burns, J., 2001. p. 479). The clinical outcome of
an AIS patient, who undergoes endovascular revascularization therapy might be affected
by a multitude of factors, type of anesthesia being just one of them. However, if we
control for some of these confounding variables by providing the highest currently
available standards of care (anesthesia team for all AIS patients regardless of the
anesthesia management technique chosen), we will be able to establish procedural
logistics sooner.
Methods
Ethical Issues
Claiming that nursing colleagues do not have enough skills and knowledge to
provide procedural sedation to AIS patients during endovascular revascularization
procedures was the main ethical dilemma that the author had to face as a result of this
project implementation. It created some tension and animosity among staff nurses. On the
other hand, it helped other nurses who shared the author’s point of view with their moral
distress. According to complexity theory, however, whenever there is a controversy, it
creates a tension that leads to increased creativity and self-organization.
A further ethical issue associated with this project pertained to allocation of
resources. Reclassification of endovascular procedures for AIS as a neurological
emergency takes the anesthesia team away from the patients who were scheduled for
elective procedures. There were times that elective procedures had to be rescheduled and
postponed. The question of who should explain the reason for procedure/surgery
cancellation to the patients was also raised. However, maintaining the status quo also
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produced an ethical dilemma. There is a close association between nursing goals and
ethics. Underlying nursing practice is the intention to do good, avoid harm, commit to
and protect the patient, and advance social policy for the greater good (Grace, 2009).
Being inadequately skilled in an intervention (incompetence), such as providing
anesthesia management to patients with AIS during endovascular revascularization
procedures creates an ethical dilemma that is against the American Nurses Association
(ANA) Code of Ethics (Grace, 2009). It violates the principles of fidelity, patient
advocacy, and protection of the patient’s welfare, especially since this particular patient
population is vulnerable and defenseless.
An additional ethical issue related to AIS revascularization therapy is that the
procedures are costly (~$30,000-40,000), not FDA approved (off-label intra-arterial tPA
administration), and currently associated with a potential serious complications (eg.
intracranial bleeding). At the same time, the presence of numerous variables affecting the
outcome of AIS (time to treatment, thrombus type, location and size of thrombus,
proceduralist’s skills, and the individual patient’s characteristics, such as collateral
circulation, comorbidities, age) makes the research investigation more difficult. These
procedures are still rare due to lack of sufficient infrastructure supporting the rapid triage
and transport of patients with AIS to stroke centers (Blackham et al., 2012). Availability
of additional and stronger scientific evidence in the future could lead us to conclude that
AIS patients have been undergoing low efficacy procedures with risks outweighing the
benefits, and the society has been exposed to wasteful spending (the justifiable
distribution of resources theory).
A separate complex ethical concept associated with this problematic clinical
practice is the issue of informed consent for an endovascular revascularization therapy.
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As described previously, it can be overwhelming to healthcare experts to make a decision
to proceed with an endovascular revascularization procedure for AIS treatment. However,
it is even more challenging to explain this procedure to a lay person, especially when it
has to be done urgently and via phone. In order to do it efficiently, “we need to
understand the patient’s beliefs, values, and goals; the patient’s/family’s ability to process
information; and psychological, physiological, or environmental factors that might
interfere with or facilitate processing of information” (Grace, 2009, p. 84). As far as
religious values discussion, a potential for blood transfusion option in case of a vessel
rupture would have to be disclosed to Jehovah’s Witness patient/family when obtaining
an informed consent.
Despite available treatment options for AIS, only 4.3% of AIS patients receive
IV tPA within the narrow treatment window, and the percentage is even smaller in
regards to intra-arterial treatment options (Jauch et al., 2013). The concept of distributive
justice in relation to AIS medical management could be related to limited public and
healthcare provider recognition of early stroke symptoms, and limited access to stroke
centers. One of the studies revealed a delay in initiation of endovascular therapy among
patients who were transported from a community hospital, as opposed to those who were
transferred directly to a comprehensive stroke center (El Khoury et al., 2012).
Setting
The project implementation took place at the University Hospital, a major
academic health center, which is an approximately 630-bed level I trauma center for both
adults and pediatric patients, and an advanced primary stroke center certified by the Joint
Commission in July 2009. The facility provides 24/7 access to the Interventional
Neuroradiology suite, where endovascular revascularization procedures for AIS can be
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performed. It has two neurointerventionalists on staff, who rotate taking calls. One of
them obtained training in Diagnostic and Interventional Neuroradiology; the other is a
neurosurgeon with additional preparation in minimally invasive neuroendovascular
procedures. This facility has been characterized by satisfactory nursing staffing ratios
protected by union rules. The institution’s radiology nurses and angiography
technologists take call during off-shifts and are available continuously, if needed for a
variety of emergency cases. At the same time, there is a shortage of anesthesiologists,
which initially posed a threat to a success of this project.
There were multiple stakeholders involved in this project including the
Emergency Department, Neurology, Radiology (CT, MRI), Interventional
Neuroradiology, Anesthesia, and the Quality Management Departments. These are
separate and semi-autonomous work units that are loosely coupled and specialize in
different areas of care delivery. Organizational loose coupling can limit the flow of
information and make it difficult to coordinate services for AIS patients (Pinelle &
Gutwin, 2006). For this reason, the facility organized the stroke committee with regular
meetings taking place every three months and led by the Stroke Program Director for
periodic evaluation of care provided to AIS patients and their outcomes. During each
meeting the hospital stroke committee made recommendations for future improvement of
processes based on the available outcomes of AIS patients.
Planning for this project took place at the same time as the hospital’s submission
processes for Magnet status. Therefore, the timing for it could not have been better since
every administrator, manager and staff nurse was actively involved in a variety of the
evidence-based projects. This project and a manuscript published on the same topic were
also used to help the facility to obtain Magnet recognition.
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Planning the Intervention
In 2011, nine endovascular revascularization procedures for AIS were performed
at the author's institution. Only one of these patients had an improvement in functional
outcomes. The statistics nationwide are not more encouraging, and the average cost of the
endovascular procedure is high (approximately $30,000-40,000), not including the costs
of the hospital stay. Moreover, neither IV tPA, nor endovascular therapy have been found
to reduce mortality from stroke (Lackland et al., 2014). After reviewing available
literature, there was not enough strong evidence to support one method of anesthesia
management vs. another. There are few restrospective studies, which compare the
outcomes of endovascular revascularization therapy based on the method of anesthesia
management. Current evidence is not sufficient to guide the choice of anesthesia for
endovascular revascularization interventions in patients with AIS (Flexman, Donovan &
Gelb, 2013).
In one of the recent studies, Jumaa et al. (2010) found that length of stay in the
intensive care unit was longer in the intubated patient group (6.5 vs. 3.2 days, p= 0.0008).
Moreover, the rate of intraprocedural complications was lower among nonintubated
patients as compared to the intubated group (6% vs. 15% respectively); however, the
difference was not statistically significant (p= 0.13). Also, there were no significant
discrepancies found in clinical outcomes and final infarct volumes on follow up imaging
between the two anesthesia management techniques. Worth noticing is the fact that all
procedures in this study were performed with the involvement of an anesthesiologist.
If prospective randomized trials continue to support moderate sedation as the
anesthesia of choice for endovascular procedures, the current use of “action nurses” at the
author’s institution would remain problematic as they are not the experts in airway
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management and hemodynamic stabilization. These situations require the presence of an
expert anesthesiologist for airway protection, emergent intubation, optimal hemodynamic
control, and prompt management of intra-procedural adverse events, such as reperfusion
injury, acute cerebral ischemia, ventricular arrhythmias, bradycardia, myocardial
ischemia, and pulmonary aspiration (Lee et al., 2004).
Although anesthesia resources are scarce at the author’s institution, AIS patients
deserve the same attention as trauma surgery patients do, since delay in intervention
could result in the patient’s death or severe disability. Therefore, the same process for the
anesthesia team request should apply to both trauma surgery as well as acute ischemic
stroke, even if elective surgeries/procedures have to be postponed.
Based on above market analysis, outcome results of the endovascular
revascularization procedures among AIS patients at the author’s institution, and a review
of the related literature, there was an obvious need for a change and process improvement.
The proposed change was the exclusive utilization of anesthesia services for
endovascular revascularization procedures among AIS patients regardless of the used
anesthesia management modality (sedation vs. general anesthesia). Anesthesia choice
would be based on clinical presentation and determined by collaboration between the
stroke neurologist, neurointerventionalist and anesthesiologist. Once endovascular
revascularization was recommended, the anesthesia and Interventional Radiology staff
would be notified, so they could start preparation for the procedure.
The leadership of this project had hopes that implementation of this new
anesthesia protocol would improve the outcomes of the AIS patients undergoing
endovascular treatment, decrease the length of hospital stay, and result in financial
savings to the facility as illustrated in Appendix B. The costs associated with the proposed
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project were related solely to anesthesia professional and technical fees. These
expenses vary depending on the type of anesthesia modality used (monitored anesthesia
care vs. general anesthesia). Any surgery/procedure over four hours, where a general
anesthetic is used costs approximately $7,300; whereas, monitored anesthesia care costs
are approximately $3,530 for the same length of time. Placement of an arterial line
(recommended for this procedure) or central line during a procedure also raises costs. In
comparison, costs for one day of stay in a Neurosurgical Intensive Care Unit (room rate)
are approximately $17,000. Therefore, if the length of stay in the Neurosurgical
Intensive Care Unit was reduced by one day only, the cost of anesthesia would be
covered, and the hospital could even save money ($17,000- $7,300= $9,700 per
procedure). Multiplying $9,700 times 9 (number of endovascular revascularization
procedures performed at the University Hospital in 2011), would bring $87,300 in
savings annually.
The process of a 30-day follow up for the functional outcome evaluation among
AIS patients and monitoring of endovascular revascularization procedures complications
has not changed as a result of this project implementation. A follow up has been
performed by the Neurology service in collaboration with the Quality Management
department. Therefore, there was no change to this process and no additional costs
associated with it. The project implementation took approximately one year (November 1,
2012 to December 1, 2013). A detailed work breakdown structure is presented in
Appendix C. The evaluation process of the project still takes place, and improvements are
being made. It is a constant work in progress.
Implementation of the Project
The implementation of the above process change started on November 1, 2012,
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after approval by the hospital administration. Before its initiation, the project plan
proposal was presented to all stakeholders (Interventional Neuroradiology faculty,
Interventional Radiology management, Stroke Program Director, Chair of Anesthesia
Department, Emergency Department management, Quality Management Department and
Stroke Committee). Stroke Committee meetings were the main source of communication
between all stakeholder. The patient’s follow up and outcome evaluation at 30 days
(either in person or as a telephone interview) has been conducted by the Neurology
service (similarly to 2011) and data for the study period between 11/01/2012 and
11/01/2013 was presented to all stakeholders at the end of the project implementation
(December 2013).
Project implementation was discussed at each Stroke Committee meeting (on
average meets every three months). Suggestions from Stroke Committee members were
carefully analyzed and if appropriate, adjustments to the project proposal were made. The
Anesthesia Chair was updated at three month intervals (more often, if needed) regarding
the project progress and anesthesia issues (i.e. anesthesia delays). The Interventional
Neuroradiology Nurse Practitioner (NP) presented the project proposal and its
implementation date to the Interventional Radiology staff (nurses and techs). Before the
project implementation, there were multiple presentations provided to the Emergency
Department and critical care float pool nurses (“action nurses”), who were previously
responsible for providing a sedation to already intubated and pharmacologically
paralyzed AIS patients during their endovascaular stroke therapy. A detailed statement of
work with scheduling plans (GANTT chart) can be found in Appendix C.
Planning the Study of the Intervention
A neurologist, who is the Stroke Program Director, was the leader of this project.
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An administrative nurse researcher, who is accountable for the Stroke Program Clinical
Operations, was responsible for collecting and presenting a summary of all stroke
(ischemic and hemorrhagic) performance measures and areas for improvement at each
committee meeting.
To assess how effectively the intervention was implemented, the Neuroradiology
NP was assigned to monitor the following performance measures: times of patients’
admission to ED or stroke symptoms onset if inpatient, start and completion times of a
CT Head and/or MRI Brain diagnostic studies, time to femoral artery puncture, and time
to intra-arterial tPA administration and/or time of clot crossing with a mechanical
thrombectomy device. These performance measures were not documented prior to this
project implementation.
A Neurology resident was responsible for monitoring the AIS patients’ response
to IV tPA, intra-arterial tPA and /or mechanical thrombectomy, their clinical outcomes at
30-days follow up either via phone or in person (with the assessment of a modified
Rankin scale), and complications (death, symptomatic intracranial hemorrhage or
ischemic stroke). Although the author’s facility has the advanced primary stroke
certification, the hospital is in the process of pursuing comprehensive stroke certification.
Therefore, the hospital’s stroke committee decided to use comprehensive stroke measures
to evaluate the clinical outcomes of AIS patients.
The baseline data prior to the project implementation is very raw (does not
include a clinical outcome assessment with a modified Rankin scale) and is presented in
Table 2. In comparison, the data for the study period between 01/01/2013 and 11/01/2013
can be found in Table 3 and reveals higher (26.5%) than the anticipated 25%
improvement in clinical outcomes at 30-day follow up among AIS patients undergoing

ACUTE ISCHEMIC STROKE

27

endovascular intervention after the project implementation. There was also decrease in
mortality rate between 2011 and the time of project implementation (33.3 % vs. 12.5%
respectively). At 30-days post-stroke follow up, three patients (37.5%) were functionally
independent (mRS ≤ 2). However, the number of AIS patient undergoing endovascular
revascularization therapy has decreased from 9 patients in 2011 to 8 patients during study
period.
Methods of Evaluation
The primary outcome of this project implementation was the clinical results as
measured with a modified Rankin scale at 30-days follow up. Neurology service
performed the assessment either in-person or via phone among AIS patients who had
undergone an endovascular revascularization therapy with intra-arterial tPA and/or
mechanical thrombectomy with the assistance of the anesthesia team.
The following were the secondary outcomes: time from the patient’s hospital
arrival to femoral puncture, time from hospital arrival to the first clot crossing with a
mechanical thrombectomy device or intra-arterial tPA administration, incidence of
serious complications (death, symptomatic intra-cranial hemorrhage, ischemic stroke),
and cost of the hospitalization. The hospital’s billing department was not willing to
provide the actual costs accrued during the patient’s admission for AIS; therefore, the
cost was roughly estimated based on the length of the hospital stay.
Analysis
Project implementation resulted in better than expected findings as there was 26.5%
actual improvement vs. 25% expected improvement in clinical outcomes among the AIS
patients undergoing endovascular revascularization procedures. There was no clearly
reported baseline for the secondary outcomes since most of the performance measures
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had not been previously reported prior to this project implementation. Based on the
available documentation, these were the outcomes for nine AIS patients who had
undergone endovascular revascularization in 2011: three patients died, six patients had no
improvement after the endovascular procedure, and one patient had a major improvement
and was discharged to the Extended Care Facility in a good condition. The following
were the post-endovascular procedure complications in 2011: two patients developed
hemorrhagic conversion of stroke, one patient had a myocardial infarction, one patient
developed nosocomial pneumonia, and one patient developed pulmonary edema and
respiratory failure as a result of exacerbation of diastolic heart failure (see Table 2).
Between November 1, 2012 and November 1, 2013 (study implementation period)
eight patients with AIS had undergone endovascular revascularization treatment. One
patient died (family withdrew care due to poor neurological prognosis), three patients had
good functional outcome (mRs ≤2), four patients had little or no improvement, one
patient had a complication of pneumonia and sepsis, and one patient had a complication
of a small hemorrhagic conversion within the left cerebellar hemisphere. Table 3
illustrates the data and clinical outcomes after the project implementation.
Results
Program Evaluation/Outcomes
Before this project implementation, “an action nurse” (ED or critical care float
pool nurse) provided sedation under the supervision of the neurointerventionalist to AIS
patients during endovascular revascularization procedures. According to the institutional
protocol, most of these patients were intubated in the ED and pharmacologically
paralyzed during the procedure for airway protection since the “action nurses” do not
have the skills to intubate the patient in cases of airway compromise. There were
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legitimate concerns regarding this practice expressed by radiology staff nurses as well as
by the critical care float pool nurses themselves. Some of the action nurses had never
previously participated in this type of procedure and felt uncomfortable managing the
airway compromise and need for emergency intubation scenarios, hemodynamics of
blood pressure (there are no clear guidelines available), cardiac issues (arrhythmias,
ischemic changes on ECG), and potential serious procedure-related complications (intracranial hemorrhage, additional ischemic stroke, pulmonary edema, brain edema).
Moreover, before the project implementation there were few retrospective studies
available that favored local anesthesia with light sedation over general anesthesia or
heavy sedation for these procedures. These studies proclaim that patients who undergo
endovascular revascularization treatment for AIS with use of light sedation have better
clinical outcomes as opposed to patients managed with general anesthesia or heavy
sedation. Although these studies have limitations (retrospective design and small sample
size), if validated with prospective randomized trials, could have questioned in the future
the utilization of the action nurses at the author’s institution due to mentioned previously
nursing scope of practice and skills restrictions.
Moreover, the clinical outcomes among AIS patients treated with intra-arterial
tPA and/or mechanical thrombectomy have been poor, especially when a high cost of the
procedure is taken under consideration ($30,000-40,000). Among nine AIS patients, who
had undergone endovascular treatment in 2011, only one patient showed improved
clinical status. There were times, when the procedure had to be cancelled in those
managed with a light/moderate sedation by an “action nurse” due to the patient’s
agitation, worsening neurological status, cardiac or airway compromise with subsequent
waste of already open supplies and time/cost of involved workforce (nurses, techs,
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anesthesia, proceduralist).
There was an obvious need for change of this questionable clinical practice of
utilizing “action nurses” for procedural sedation during endovascular revascularization
therapy. The change in practice was initially proposed by the Interventional
Neuroradiology NP at one of the facility’s stroke committee meetings. It was supported
by the Stroke Program director and the rest of the committee. The Stroke Program
Director issued an official letter to the hospital administration and the anesthesia
department chair. At first, there was no response. Later, concerns about an insufficient
anesthesia workforce were raised. Publishing a manuscript in the “Journal of Radiology
Nursing,” which described this controversial clinical issue, and sharing a copy of this
article with all involved stakeholders increased their level of engagement in this project.
It also started a public discussion regarding the endovascular revascularization
procedures logistics. The author, who published this manuscript received a positive
responses from a nationwide interventional radiology community, as well as invitations
for presentations and further publishing, even from anesthesiology journals. This project
also helped to improve the process of stroke performance measures documentation at the
author’s facility. Moreover, it motivated the project stakeholders to proceed towards
obtaining a comprehensive stroke certification. The author and Neuroradiology NP
played a significant role during this project implementation. She was the initiator of this
idea and worked closely with both of her neurointerventionalists, who were very
supportive and wanted this project to succeed.
Having anesthesia expertise and excellent collaboration among all stakeholders
through their active participation in the Stroke Committee was the strength of this project.
Its weakness was a lack of adequate anesthesia workforce at the author’s institution and
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additional costs associated with the use of the anesthesiologists. Currently, AIS
revascularization cases are considered a “neurologic emergency” at the University
Hospita.l. As a result, anesthesia is readily available, even if an elective procedure has to
be rescheduled/postponed. On the other hand, endovascular ischemic stroke procedures
remain among the least common procedures that neurointerventionalists perform (nine
procedures in 2011). Therefore, this number should not be too overwhelming to the
anesthesia workforce at the author’s facility. As the number of endovascular
revascularization procedures grows, it might necessitate opening of an additional
anesthesia position. However, it should be financially justified by the savings this project
could bring to the institution. Success of this project could help create new protocols for
anesthesia management for AIS during endovascular revascularization procedures, not
only at the author’s institution, but nationwide, and motivate researchers to conduct
prospective, randomized studies on the efficacy of these costly ($30,000-40,000 per
procedure) interventions (Appendix A, SWOT Analysis).
Despite a successful project implementation, there are still times when procedural
sedation is provided by a critical care float pool nurses, if anesthesia is not immediately
available. Most frequently, however, it applies to the inpatients who developed stroke
symptoms while in the hospital due to different health problems. Therefore, the hospital
staff directly involved in care of these patients is familiar with their past medical, surgical
history, the time of stroke symptoms onset, and the patients’ fasting status.
Discussion
Summary
This project implementation changed a controversial clinical practice and
provided the AIS patients at the author’s institution with the highest standards of care
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available based on current knowledge. It also helped to improve the clinical outcomes of
the endovascular revascularization procedures for AIS by 26.5% within 1 year of the
project implementation. Secondary gain of this project was an initiation of monitoring of
the endovascular procedures outcomes and performance measures. Unfortunately, the
project implementation had not decreased the length of hospital stay among AIS patients
as expected. The average length of hospital stay increased during the study period as
compared to 2011 (16.75 days vs. 14.9 days, respectively). However, the mortality rate
was higher in 2011, and three patients from the project group developed ischemic stroke
as inpatients during their hospitalization due to different reasons (cardiac surgery, renal
transplant and trauma patient), which could affect their length of hospital stay.
Shortage of the anesthesia workforce at the author’s facility and controversy
about whether it is a “neurological emergency” were the main obstacles to this project
implementation. Lack of adequate anesthesia force and associated time delays were
additional constrains of this project. Having more research supporting intra-arterial tPA
revascularization therapy and subsequent FDA approval would make this approach more
convincing to all stakeholders worldwide. An additional anticipated threat to the project
success was the patient population the author’s facility serves. A significant percentage of
patients admitted to the University Hospital are low income, uninsured and/or homeless.
This group of patients can be easily lost to follow up. Moreover, uninsured patients can
create additional financial burdens for the institution and not participate in bringing in
funds to cover additional anesthesia costs.
The driving force of this project was the explosion of studies analyzing
mechanical thrombectomy devices that could be used beyond the 6-hr window. Intraarterial tPA administration continues to be an off-label procedure due to lack of sufficient
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scientific evidence supporting its use and it has to be delivered within 6 hours of
symptoms onset. This makes an implementation of intra-arterial thrombolytic therapy
more difficult.
The topic of this project is controversial and has never been analyzed from this
point of view in the nursing or medical literature before. It is one of many healthcare
practice issues that the author has questioned during her nursing career based on
observations and experiences, in order to improve the standards of care and patient
outcomes. The uniqueness of this project is its originality. While others have compared
outcomes of AIS patients undergoing endovascular revascularization with sedation versus
general anesthesia, no one had analyzed the differences in outcomes between two groups
of patients; those managed by the anesthesia team versus those managed by the nonanesthesiologist team. Providing anesthesia management to a group of patients with a
complex medical or unknown history, such as AIS patients, without being adequately
skilled and familiar with Interventional Radiology, during an off-shift creates an ethical
dilemma, and it is against the American Nurses Association Code of Ethics (Grace,
2009). Implementation of this project hopefully helped nurses with their moral distress
and increased the patients’ safety.
The author anticipates that publishing a manuscript on this topic will start a public
discussion of this problematic clinical practice with the involvement of the other
stakeholders and professional organizations that share the same concerns (e.g. American
Heart Association). The author hopes that the positive changes this project brings will
improve the AIS patients’ outcomes, decrease the length of hospital stay, and finally
result in reduction of total healthcare costs. Beyond the financial objectives, this project
could improve the outcomes of stroke patients, and increase their independence and
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quality of life. The same changes could eventually be adopted by the other institutions
nationwide, and perhaps worldwide.
The author believes that nurses who are educated and knowledgeable, and possess
leadership skills, can increase collaboration with physicians and other healthcare
providers to positively affect patients’ outcomes. Moreover, nurses, who share their
knowledge by publishing their findings are given credit for it. This project is an example.
Relation to Other Evidence
As mentioned previously, there are few retrospective studies (see Appendix D)
that discuss the advantages and limitations of the anesthesia and sedation practices used
for AIS patients during endovascular revascularization procedures. They attempt to
convey that patients who undergo these procedures with general anesthesia, have
worse clinical outcomes. However, the available evidence has its limitations such as
retrospective design and small sample sizes, and should be analyzed with caution. There
was a similar attempt undertaken in the past regarding patients undergoing elective
carotid endarterectomy for carotid stenosis. While the initial retrospective studies favored
local anesthesia, this was not validated with a prospective randomized trial, which
showed no difference in outcomes between two groups of patients (Vaniyapong et al.,
2013).
Conclusions
There are but a few retrospective studies that attempt to show superiority of local
anesthesia with conscious sedation as compared to general anesthesia during
endovascular revascularization procedures among AIS patients. Until higher quality
evidence is available, monitored anesthesia care with intravenous sedation or general
anesthesia (both provided by the anesthesia team), depending on the clinical situation,
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seems to be the safest anesthesia management plan during endovascular procedures for
AIS. The anesthesia team is best equipped to handle procedural complications, if they
occur. In addition, in light of controversy surrounding endovascular revascularization
procedures, it is imperative to provide optimal hemodynamic management and
monitoring of these patients for possible complications such as reperfusion bleeding
(Leifer et al., 2011). There are so many potential contributing factors (type of anesthesia
being one of them) affecting the outcomes of these patients; however, if we control for
some of them, we will be able to establish procedural logistics sooner.
Further prospective research studies are needed to determine what anesthesia
management is optimal for patient safety and functional outcomes, and to create standard
anesthesia/sedation protocols. Also, future prospective studies are desired to compare the
outcomes between two groups of AIS patients; those who have been managed by the
anesthesia team vs. those who have been managed by the non-anesthesiologist.
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General Anesthesia
Advantages:
Limitations:
• Patient immobility
• Time delay
• Perceived procedural safety with
• Lack of adequate anesthesia workforce
mechanical manipulation
• Inability to monitor the patient’s
• Improved procedural efficacy
neurological status
• Better imaging (no motion artifact)
• Higher risk of stroke as a result of
hypotension during anesthesia
• Optimal management of procedureinduction
related complications
• Higher risk of cardiovascular
complications
Sedation & local anesthesia
Limitations:
Advantages:
• Neurointerventionalist cannot fully
• Ability to start the procedure in a
concentrate on the procedure
timely manner (“Time is brain”)
• Risk of aspiration and emergency
• Ability to monitor the patient’s
intubation
neurological status during the
procedure and adjust the approach, if
• Risk of not being able to control blood
necessary
pressure adequately
• No risks of general anesthesia
• Risk of not being able to manage
• Lower procedure costs
cardiac complications adequately
• Higher risk of aborting the procedure
and costs associated with it
• Patient factor:
- Patient’s mobility
- Non-English speaking
- Hard of hearing
- Severe anxiety, agitation
- Aphasia, dementia
- Not able to tolerate prolonged supine
position (back pain, heart failure, etc.)
- Inability to follow commands

Table 1. Advantages and limitations of different anesthesia management modalities

ACUTE ISCHEMIC STROKE
Date

Response to
endovascular
therapy
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Complications

Outcome

Length of
Hospital Stay

01/24/2011

01/26/2011

02/24/2011

Mercy retriever
only. No
recanalization.
No improvement.
Combined IV
and IA tPA.
Major
improvement.
IA tPA and
Mercy retriever,
Unable to
recanalize MCA.
No improvement.

No
complications

DC to SNF
hemiplegic and
aphasia

10 days

No
complications

DC to SNF (but
in very good
shape)

8 days

DC to subacute
care facility on a
ventilator
G-tube
Tracheostomy

35 days

Died of massive
stroke. Family
withdrew care on
04/25/2011
DC home. Died
on 07/01/2011.

12 days

04/13/2011

IA tPA only. No
improvement.

NSTEMI
Exacerbation of
dHF
Pulmonary
edema
Respiratory
failure
Hemorrhagic
conversion
No
complications

06/06/2011

IA tPA only. No
improvement.

No
complications

06/24/2011

Received
Nosocomial
bridging dose IV pneumonia
tPA and IA tPA
plus Mercy
retriever. No
recanalization.
No improvement.

Transferred to
Kaiser with
global aphasia
and dense right
hemiplegia.

5 days

09/26/2011

Mechanical
thrombectomy
only. No
recanalization.
No improvement.
Full dose IV tPA
plus mechanical
thrombectomy
IV tPA plus
mechanical
thrombectomy.
No
recanalization.
No improvement.

No
complications

Left hemiplegia,
dysarthria

18 days

Hemorrhagic
conversion

Patient expired
on 12/11/2011

4 days

No complication

DC to SNF with
global aphasia
and G-tube.
Regained right
upper and lower
extremity
movement.

21 days

12/07/2011

11/09/2011

21 days

Table 2. Endovascular revascularization therapy for acute ischemic stroke at the
University Hospital in 2011.

ACUTE ISCHEMIC STROKE
Date

11/05/2012

11/15/2012

Response to
Endovascular
Therapy
Mechanical
thrombectomy with
Trevo device
Successful
recanalization.
Mechanical
thrombectomy with
Trevo device with
complete
recanalization of

43
Complications

Outcome

Length of
Hospital Stay

None

Full recovery.
Neurologically
intact.
mRS≤ 1

58 days

Small
hemorrhagic
conversion
within the left
cerebellar

DC to SNF.
Oriented to self,
ability to follow
simple
commands,

14 days

basilar artery.

hemisphere

Full dose of IV tPA
plus mechanical
thrombectomy with
Trevo device.
Technically
successful
recanalization of the
basilar and right
vertebral arteries.
IV tPA plus IA tPA
administration (2
mg). Partial
recanalization of
basilar artery.

Large right
cerebellar,
occipital, and
thalamic
strokes.

04/30/2013

IA tPA
administration (2
mg). No
recanalization.
No improvement.

None

05/23/2013

IV tPA; no
endovascular
treatment.
Recanalization of
left ICA after IV
tPA treatment

05/24/2013

IA tPA (2 mg) plus
mechanical
thrombectomy with
Trevo device.
Recanalization of
left MCA M1
segment.

12/31/2012

03/26/2013

Pneumonia,
sepsis

improved right
hemiparesis.
mRS= 3
Family withdrew
care due to poor
neurological
prognosis.
Patient expired.
mRS= 6

3 days

Transferred to
Kaiser. Able to
withdraw
extremities to
pain; opens eyes
to name and
light
mRS= 5
Remained
aphasic.
mRS= 4

2 days

None

DC to SNF with
right hemiplegia,
dysarthria and
dysphagia. Gtube placement
mRS= 5

15 days

None

DC to assisted
living facility
with proximal
right arm
weakness;
otherwise neuro
exam WNL.
mRS≤ 2

10 days

18 days

08/16/2013

IA tPA (2 mg) and
mechanical
thrombectomy with
Trevo device.
Recanalization of
left MCA M1
segment

None

Some expressive
aphasia, but no
other
neurological
deficits.
mRS≤ 2

14 days

Table 4. Endovascular revascularization therapy for acute ischemic stroke at the
University Hospital between November 1, 2012 and November 1, 2013.
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Appendix A (SWOT Analysis)

Strengths

Weaknesses

•

Improved AIS patient outcomes

•

•

Higher quality of life among AIS
patients (more independent, lower
burden to the society)

Lack of adequate anesthesia
workforce

•

Additional costs due to anesthesia
expenses

•

Lengthy endovascular procedures
(4-5 hours) taking more anesthesia
time

•

Decreased length of hospital stay
(lower costs due to shorter stay)

•

Rare procedures (not too

•

overwhelming to anesthesia; 8-10
procedures/year)

•

Not enough strong evidence
supporting change

Having procedure protocol and
structure could decrease the time
from the patient admission to
femoral puncture/revascularization

•

Rare procedures (hard to conduct
randomized trials and not enough
practice for NI)

•

Noninsured patients (additional
expense to the institution)

Opportunities

Threats

•

Justification for another anesthesia
position opening

•

Delayed procedure start due to
inadequate anesthesia workforce

•

Good collaboration among
stakeholders (practice for future
projects)

•

Loss of patients to follow up (low
income, homeless patient
population)

•

Decreased length of hospital stay
(more ICU beds available)

•

•

Creation of new anesthesia
protocols nationwide/worldwide

•

Motivation for researchers to
investigate this issue thoroughly
with prospective studies (would
provide better evidence about
efficacy of the procedure)

Availability of stronger evidence
could prove low efficacy of the
procedure (risks outweigh the
benefits) and demonstrate wasteful
spending ($30,000-40,000 per
procedure)

ACUTE ISCHEMIC STROKE
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Appendix B (Proposed Budget)

Cost of hospital services

Procedure cost per
patient
Anesthesia cost per
patient
Cost of nursing (action
nurse & Radiology RN)
per patient
Cost of stay in
NeuroICU

Cost of AIS
revascularization
procedure with
anesthesia team
$30,000

Cost of AIS
revascularization
procedure with RN
sedation
$30,000

$7,300

$0.00

$700.00

$700.00

$17,000 x 1 day=
$17,000

$17,000 x 2days=
$34,000

($17,000/day/patient)
Total cost of
hospitalization per
patient
Total cost of
hospitalization x 9
patients/year
Hospital savings per
year

$55,000

$64,700

$495,000

$582,300

$87,300

ACUTE ISCHEMIC STROKE
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Project evaluation

Presentation of 1 year project results/outcomes to all stakehoders (Stroke Committee, anesthesia, INR, Neurology, Quality Management)

Project proposal presentation to IR staff and action nurses

Project updates presentation to Anesthesia Chair/Department

Project updates presentation at Stroke Committee meetings

Project proposal presentation to a hospital Stroke Committee and Quality Management representatives

Project implementation after approval and changes to a stroke protocol

Project proposal presentation to a Chair of Anesthesia Department and Stroke Program Director

Project proposalpresentation to the Interventional Neuroradiology (INR) faculty and IR management

Project Milestones and Evaluation

Year

Sep

Aug

Jul

Jun

May

2013

Apr

Mar

Feb

Jan

Dec

Nov

Oct

Sep

Aug

Jul

Jun

2012

May

Apr

Mar

Feb

Jan

Dec

Nov

Oct
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Appendix D (JHNEBP Research Evidence Appraisal)

Author
(year)
Abou-Chebl
et al. (2010)

Jumaa et al.
(2010)

Study
Design/Randomization/Sa
mple Size
Retrospective
No randomization
N= 980

Retrospective
No randomization
N= 126

Study Conclusions

Study Limitations

Evidence
Rating

After the study results were adjusted
for age, initial NIHSS score, time to
femoral artery puncture, time to vessel
opening, recanalization outcome, and
intracerebral bleeding complication,
patients placed under GA were at
significantly higher risk of a poor
outcome. Conscious sedation seemed
to be as safe as GA with respect to the
procedural complication of intracranial
hemorrhage.

Higher NIHSS scores on
admission (17±5
vs. 16±6, p<0.01) GA vs.
conscious sedation group
respectively.
Not controlling for
comorbidities, patient
clinical status and
endovascular techniques.
The investigators did not
address the
issue of emergency
intubation since they
could not differentiate
between the group of
patients who were
intubated before the
procedure and those who
were intubated
emergently during the
procedure. A clear
definition of conscious
sedation and who
managed it was not
provided in the study
methodology.

3C

The length of stay in the ICU was
longer for the general anesthesia group
(6.5 vs. 3.2 days,
p=0.0008). The intraprocedural
complications rate was lower among
nonintubated patients as compared to
the intubated group (6% vs. 15%
respectively,
p=0.13); however, the difference was
not statistically significant. There were
no significant discrepancies found in
clinical outcomes and final infarct
volumes on follow up imaging
between the two anesthesia

Small sample size.
Difference in baseline
NIHSS score (17.6 [1422] vs. 15.1 [12-18])
between two groups of
patients (intubated state
vs. non-intubated state,
respectively).
Missing data regarding
time from decision to
intervene to groin
puncture, intra-procedural
blood pressure variations
and PCO2 values (acute

3C

McDonagh
(2010)

Retrospective survey
No randomization
N= 49/68 respondents (72%
response rate)

Nichols et al.
(2010)

Retrospective
No randomization
N= 75

Davis et al.
(2012)

Retrospective
No randomization
N= 96

management techniques. Regardless of
the
anesthesia management modality
(intubated state vs. nonintubated state),
all procedures in this study were
performed with the involvement of an
anesthesiologist.

hypocapniavasodilation).

The most frequently used anesthesia
type was general anesthesia, followed
by conscious sedation (nurse
administered), then monitored
anesthesia care (MAC) administered
by the anesthesia
team, and finally local analgesia alone.
Preference for GA was associated with
a type of
endovascular procedure. Mechanical
thrombectomy was most frequently
associated with
a request for GA (55% of
respondents). General anesthesia was a
preferred practice for
patients with a NIHSS score >15 (53%
of respondents) and patients with
brainstem stroke (51% of respondents).
Lower levels of sedation and male
gender were correlated with good
clinical outcome. The highest levels of
sedation, including
pharmacological paralysis, were the
only independent predictors of death.
Mild or no sedation, and no internal
carotid artery occlusion were the
predictors of successful
reperfusion. The study found a
significantly higher level of infection
(pneumonia and/or
sepsis) in patients who received heavy
sedation (p= 0.02). High sedation level
remained a predictor of poor clinical
outcome and death even after baseline
NIHSS score was accounted for in
multivariable analysis.

Small sample size. Recall
bias (self-reported
perceptions of 49 NI’s
from the SVIN). Poor
external validity (only
SVIN members were
surveyed). Missing data
regarding the NI’s
involvement in choosing
anesthesia type, the
ventilator/critical care
management during the
case, and specific criteria
for requesting GA.

3C

Small sample size.
Baseline NIHSS score
varied widely between
the different levels of
sedation (p= 0.03). The
researchers were not able
to precisely identify the
types of
anesthesia medications
used, the duration of the
treatment, the times of
administration in
relation to the
angiographic procedure,
and the route of
administration. The
authors did not specify
who provided the
anesthesia management
during the procedure.

3C

Mortality rate was higher in the
general anesthesia group. After
adjusting for baseline stroke severity,
sedation and no incidence of

Small sample size.
No clear definition of
baseline blood pressure
value available. The

3C

hypotension (blood pressure ≤ 140
mmHg) were predictors of a good
functional outcome. The authors
reported a good functional
outcome in fifteen percent of patients
managed with general anesthesia, as
opposed to
sixty percent of patients who were
managed with sedation (p < 0.001).

NIHSS score was higher
in patients who received
GA.

Soize et al.
(2012)

Prospective, single center
No randomization, no
control group
N= 36 (consecutive
patients)

The primary outcomes measured at 3months follow up were mortality rate
and functional outcome. Twenty two
patients (61.1%)
presented at three months follow up
with good functional outcomes and ten
patients (27.8%) had a poor outcome
or died. Successful revascularization
was accomplished in twenty eight
(77.8%) patients. The anesthesia team
was used only in “severe cases,” the
definition of which was not provided;
whereas conscious sedation with IV
midazolam was administered by the
stroke neurologist.

Small sample size.
No control group, no
randomization.
High complication rate:

3C

Li et al.
(2013)

Retrospective
No randomization
N= 109

General anesthesia and post-procedural
hyperglycemia (blood glucose > 200
mg/dL) were the most important
predictors of mortality (mortality rate
40% vs. 22% when comparing general
anesthesia vs. conscious sedation
group, p= 0.045). The time from AIS
symptoms onset to recanalization and
the length of endovascular
revascularization procedure were
longer in the general anesthesia group.
There were no statistically significant
differences between general anesthesia
and conscious sedation groups as far as
procedure-related
complications (p= 0.997) and the
patients’ functional outcome at
discharge (p= 0.631).

Small sample size.
Higher incidence of
posterior circulation
stroke among the GA
group patients (20% vs.
4% in CS group). Only
patients treated with
Merci retriever and
Penumbra thrombectomy
devices were included in
this study (no cases with
the latest generation of
stent-retriever
technology). Before
2011, general anesthesia
was used routinely for all
patients undergoing
endovascular treatment
for AIS.
Serial glucose levels
could not be consistently
collected retrospectively;
therefore, definite
conclusions cannot be
made. Lack of long-term

3C

90-day clinical follow up.
Absence of detailed
information regarding
stroke severity, size and
location.

